Close
ACHEMA MIDDLE EAST 2026

Drug Development Benchmarks Driven By Quality By Design

A paper that has been published in the European Journal of Pharmaceutics and Biopharmaceutics has gone on to review the present application status of...

Global Advanced Empty Capsules To See A Growth of 7.4% CAGR

The Worldwide Advanced Empty Capsule sector is anticipated to be worth US$ 905.6 million this year in 2023 and is expected to key in...

First Ever List of Critical Medicines Published By Europe

Along with the European Commission, the Heads of Medicines Agencies- HMA as well as the European Medicines Agency-EMA have gone on to publish the...

The White House Looks For Rebates Over Drug Price Fixing

Pharma companies in the US have come under fire yet again from the White House. This is the second time in two weeks that...

Pharma Spectrum – Using Connected Drug Delivery Devices

The market when it comes to connected drug delivery devices is going through rapid growth, with an expected annual market growth rate of more...

NPRA In Malaysia Has Broadened Reference Approval Guidelines

The National Pharmaceutical Regulatory Agency- NPRA of Malaysia has recently gone on to revise its guidelines with regards to the approval pathways for medicines that...

New Pharma Legislation May Affect Europe R&D Significantly

The European Federation of Pharmaceutical Industries and Associations- EFPIA happens to be consistently applying pressure on the Commission for its pharmaceutical legislation. In a...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...